miR-205-5p drives endothelial dysfunction and senescence in pulmonary fibrosis
JCI Insight · 08.07.2026 · 11 (13)
DOI: 10.1172/jci.insight.201842 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 28.05.2026. Verfasst von Giuseppe Muscato und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy. Hauptthemen laut MEDLINE: MicroRNAs, Idiopathic Pulmonary Fibrosis, Cellular Senescence, Endothelial Cells. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a fatal, aging-related disease characterized by persistent lung fibroblast activation, progressive lung scarring, and several vascular abnormalities. We have previously demonstrated that aging-associated vascular dysfunction drives maladaptive endothelial responses to injury and exacerbates lung fibrosis via secretion of profibrotic endothelial cell–derived factors. However, regulatory mechanisms governing endothelial dysfunction during progressive lung fibrosis remain poorly understood. Here, using preclinical mouse models of progressive lung fibrosis as well as human IPF lungs, we demonstrate that miR-205-5p was overexpressed in lung endothelial cells (ECs) from fibrotic lungs and coordinated gene expression programs implicated in endothelial dysfunction and progressive fibrosis. Mechanistically, miR-205-5p induced senescence in lung ECs, mirroring the senescent phenotype of IPF lung ECs. Consistently, conditioned medium derived from lung ECs overexpressing miR-205-5p promoted lung fibroblast activation. Importantly, miR-205-5p inhibition in IPF lung ECs attenuated endothelial senescence and limited paracrine fibroblast activation. Finally, inhibition of miR-205-5p in vivo preserved the pulmonary vascular network and attenuated lung fibrosis progression in aged mice challenged with bleomycin. Collectively, our findings support what we believe to be a novel connection among lung endothelial miR-205-5p, endothelial senescence, and profibrotic alteration of the endothelial secretome and highlight miR-205-5p inhibition as a potential therapeutic intervention for pulmonary fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
- Department of Medicine, Stritch School of Medicine, and.
- Department of Cell and Molecular Physiology, Loyola University Chicago, Maywood, Illinois, USA.
- Department of Medicine, Boston University, Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.
- Department of Zoology, Faculty of Science, Assiut University, Assiut, Egypt.
- Department of Medicine, University of California, San Diego, La Jolla, California, USA.
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Muscato, G., Roos, B. B., Harris, S., Cai, X. T., Civettini, G., Sciacca, E., Raslan, A. A., Castaldi, A., Elliot, S., Glassberg, M. K., Vancheri, C., Tschumperlin, D. J., Ligresti, G., & Caporarello, N. (2026). miR-205-5p drives endothelial dysfunction and senescence in pulmonary fibrosis. JCI Insight, 11(13). https://doi.org/10.1172/jci.insight.201842
Vancouver
Muscato G, Roos BB, Harris S, Cai XT, Civettini G, Sciacca E, et al. miR-205-5p drives endothelial dysfunction and senescence in pulmonary fibrosis. JCI Insight. 2026;11(13). doi:10.1172/jci.insight.201842
BibTeX
@article{Muscato2026,
author = {Muscato, Giuseppe and Roos, Benjamin B and Harris, Sharonda and Cai, Xiaoyu Tracy and Civettini, Gina and Sciacca, Enrico and Raslan, Ahmed A and Castaldi, Alessandra and Elliot, Sharon and Glassberg, Marilyn K and Vancheri, Carlo and Tschumperlin, Daniel J and Ligresti, Giovanni and Caporarello, Nunzia},
title = {miR-205-5p drives endothelial dysfunction and senescence in pulmonary fibrosis},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {13},
doi = {10.1172/jci.insight.201842}
}
EUVIMED